Unlocking the Power of the Genome
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Illumina | Sequencing and array solutions to fuel genomic discoveries
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Eagle Genomics biotech, it services, deeptech, Software Development | Other 12 Oct 2023 | | ||
mind Health healthtech, Online Audio and Video Media | Other 28 Apr 2024 | | ||
Trecento AM Financial Services | Other 13 Oct 2022 | | ||
CPGR biotech, deeptech, Biotechnology Research | Other 31 May 2024 | | ||
Envisagenics biotech, deeptech, Biotechnology Research | Other 19 Nov 2022 | | ||
Center for Genomic Interpretation biotech, deeptech, Hospitals and Health Care | Other 31 Jan 2023 | | ||
Front Line Genomics Media Production | Other 6 Nov 2023 | | ||
UK Biobank deeptech, healthtech, Research Services | Other 5 Dec 2023 | | ||
Nature Portfolio Book and Periodical Publishing | Other 29 Nov 2023 | | ||
Biocom California Biotechnology Research | Other 18 Dec 2023 | |